| P value | Hazard ratio | 95 % confidence interval |
---|---|---|---|
Model A | Â | Â | Â |
 Age | 0.69 | 0.99 | 0.96–1.02 |
 Gender (male vs. female) | 0.32 | 1.44 | 0.71–2.91 |
 Hemoglobin (≤9 g/dl vs. >9 g/dl) | 0.31 | 1.47 | 0.70–3.11 |
 Urinary protein (per g/24 hour) | 0.02 | 1.29 | 1.05–1.58 |
 Plasma CFH levels (per 50 μg/ml increase) | 0.03 | 0.85 | 0.73–0.98 |
Model B | Â | Â | Â |
 Age | 0.72 | 0.99 | 0.96–1.03 |
 Gender (male vs. female) | 0.36 | 1.39 | 0.69–2.82 |
 Total crescents (%) (>50 % vs. ≤50 %) | 0.26 | 1.69 | 0.68–4.17 |
 Urinary protein (per g/24 hour) | 0.09 | 1.21 | 0.97–1.52 |
 Plasma CFH levels (per 50 μg/ml increase) | 0.03 | 0.85 | 0.73–0.98 |
Model C | Â | Â | Â |
 Age | 0.31 | 1.02 | 0.99–1.05 |
 Gender (male vs. female) | 0.75 | 1.12 | 0.55–2.29 |
 Initial serum creatinine (per mg/dl) | <0.001 | 1.24 | 1.12–1.36 |
 Urinary protein (per g/24 hour) | 0.002 | 1.34 | 1.12–1.62 |
 Plasma CFH levels (per 50 μg/ml increase) | 0.57 | 0.96 | 0.83–1.11 |